Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel Free MBX Stock Alerts

Microbix Biosystems (MBX) Competitors

Microbix Biosystems logo
C$0.30 -0.01 (-3.23%)
As of 07/24/2026 03:23 PM Eastern
Compare

MBX vs. IPA, HBP, SCYB, COM, and NVH

Should you buy Microbix Biosystems stock or one of its competitors? MarketBeat compares Microbix Biosystems with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Microbix Biosystems include ImmunoPrecise Antibodies (IPA), Helix BioPharma (HBP), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), and Novoheart (NVH). These companies are all part of the "biotechnology" industry.

How does Microbix Biosystems compare to ImmunoPrecise Antibodies?

ImmunoPrecise Antibodies (CVE:IPA) and Microbix Biosystems (TSE:MBX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, profitability, dividends, risk, media sentiment and institutional ownership.

0.2% of Microbix Biosystems shares are owned by institutional investors. 14.0% of Microbix Biosystems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Microbix Biosystems has lower revenue, but higher earnings than ImmunoPrecise Antibodies. Microbix Biosystems is trading at a lower price-to-earnings ratio than ImmunoPrecise Antibodies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ImmunoPrecise AntibodiesC$19.47M8.33-C$22.19M-C$0.89N/A
Microbix BiosystemsC$14.81M2.78C$3.39M-C$0.04N/A

ImmunoPrecise Antibodies has a net margin of 0.00% compared to Microbix Biosystems' net margin of -38.62%. ImmunoPrecise Antibodies' return on equity of 0.00% beat Microbix Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
ImmunoPrecise AntibodiesN/A N/A N/A
Microbix Biosystems -38.62%-21.02%3.82%

In the previous week, ImmunoPrecise Antibodies' average media sentiment score of 0.00 equaled Microbix Biosystems'average media sentiment score.

Company Overall Sentiment
ImmunoPrecise Antibodies Neutral
Microbix Biosystems Neutral

Summary

ImmunoPrecise Antibodies and Microbix Biosystems tied by winning 5 of the 10 factors compared between the two stocks.

How does Microbix Biosystems compare to Helix BioPharma?

Microbix Biosystems (TSE:MBX) and Helix BioPharma (TSE:HBP) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, risk, media sentiment, valuation, earnings, profitability and institutional ownership.

Microbix Biosystems has a beta of 0.675979, meaning that its share price is 32% less volatile than the broader market. Comparatively, Helix BioPharma has a beta of 0.431088, meaning that its share price is 57% less volatile than the broader market.

Helix BioPharma has a net margin of 0.00% compared to Microbix Biosystems' net margin of -38.62%. Microbix Biosystems' return on equity of -21.02% beat Helix BioPharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Microbix Biosystems-38.62% -21.02% 3.82%
Helix BioPharma N/A -21.54%-279.98%

In the previous week, Microbix Biosystems' average media sentiment score of 0.00 equaled Helix BioPharma'saverage media sentiment score.

Company Overall Sentiment
Microbix Biosystems Neutral
Helix BioPharma Neutral

0.2% of Microbix Biosystems shares are owned by institutional investors. Comparatively, 0.0% of Helix BioPharma shares are owned by institutional investors. 14.0% of Microbix Biosystems shares are owned by company insiders. Comparatively, 2.2% of Helix BioPharma shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Microbix Biosystems has higher revenue and earnings than Helix BioPharma. Helix BioPharma is trading at a lower price-to-earnings ratio than Microbix Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microbix BiosystemsC$14.81M2.78C$3.39M-C$0.04N/A
Helix BioPharmaN/AN/A-C$50.55M-C$0.04N/A

Summary

Microbix Biosystems beats Helix BioPharma on 8 of the 10 factors compared between the two stocks.

How does Microbix Biosystems compare to Scythian Biosciences?

Microbix Biosystems (TSE:MBX) and Scythian Biosciences (CVE:SCYB) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, valuation, profitability, risk, dividends, earnings and analyst recommendations.

0.2% of Microbix Biosystems shares are owned by institutional investors. 14.0% of Microbix Biosystems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Scythian Biosciences has a net margin of 0.00% compared to Microbix Biosystems' net margin of -38.62%. Scythian Biosciences' return on equity of 0.00% beat Microbix Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Microbix Biosystems-38.62% -21.02% 3.82%
Scythian Biosciences N/A N/A N/A

In the previous week, Microbix Biosystems' average media sentiment score of 0.00 equaled Scythian Biosciences'average media sentiment score.

Company Overall Sentiment
Microbix Biosystems Neutral
Scythian Biosciences Neutral

Microbix Biosystems has higher revenue and earnings than Scythian Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microbix BiosystemsC$14.81M2.78C$3.39M-C$0.04N/A
Scythian BiosciencesN/AN/AN/AN/AN/A

Summary

Microbix Biosystems beats Scythian Biosciences on 4 of the 6 factors compared between the two stocks.

How does Microbix Biosystems compare to 138267 (COM.TO)?

Microbix Biosystems (TSE:MBX) and 138267 (COM.TO) (TSE:COM) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings, analyst recommendations and media sentiment.

0.2% of Microbix Biosystems shares are held by institutional investors. 14.0% of Microbix Biosystems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Microbix Biosystems has higher revenue and earnings than 138267 (COM.TO).

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microbix BiosystemsC$14.81M2.78C$3.39M-C$0.04N/A
138267 (COM.TO)N/AN/AN/AN/AN/A

In the previous week, Microbix Biosystems' average media sentiment score of 0.00 equaled 138267 (COM.TO)'saverage media sentiment score.

Company Overall Sentiment
Microbix Biosystems Neutral
138267 (COM.TO) Neutral

138267 (COM.TO) has a net margin of 0.00% compared to Microbix Biosystems' net margin of -38.62%. 138267 (COM.TO)'s return on equity of 0.00% beat Microbix Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Microbix Biosystems-38.62% -21.02% 3.82%
138267 (COM.TO) N/A N/A N/A

Summary

Microbix Biosystems beats 138267 (COM.TO) on 4 of the 6 factors compared between the two stocks.

How does Microbix Biosystems compare to Novoheart?

Microbix Biosystems (TSE:MBX) and Novoheart (CVE:NVH) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, media sentiment, institutional ownership and valuation.

In the previous week, Microbix Biosystems' average media sentiment score of 0.00 equaled Novoheart'saverage media sentiment score.

Company Overall Sentiment
Microbix Biosystems Neutral
Novoheart Neutral

Novoheart has a net margin of 0.00% compared to Microbix Biosystems' net margin of -38.62%. Novoheart's return on equity of 0.00% beat Microbix Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Microbix Biosystems-38.62% -21.02% 3.82%
Novoheart N/A N/A N/A

Microbix Biosystems has higher revenue and earnings than Novoheart. Novoheart is trading at a lower price-to-earnings ratio than Microbix Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microbix BiosystemsC$14.81M2.78C$3.39M-C$0.04N/A
NovoheartC$423.50K236.08-C$7.17M-C$0.04N/A

0.2% of Microbix Biosystems shares are held by institutional investors. 14.0% of Microbix Biosystems shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Microbix Biosystems beats Novoheart on 6 of the 10 factors compared between the two stocks.

Get Microbix Biosystems News Delivered to You Automatically

Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MBX vs. The Competition

Export
MetricMicrobix BiosystemsBiotechnology IndustryMedical SectorTSE Exchange
Market CapC$41.25MC$434.80MC$6.88BC$12.48B
Dividend Yield2.30%3.90%2.67%6.19%
P/E Ratio-7.323.1627.0036.95
Price / Sales2.786,592.20492.309.44
Price / Cash4.1313.1350.5482.29
Price / Book1.6583.7010.284.39
Net IncomeC$3.39M-C$96.07MC$3.60BC$299.09M
7 Day PerformanceN/A-0.64%-1.29%0.61%
1 Month Performance-1.64%-1.04%-0.38%1.06%
1 Year Performance3.45%56.21%18.32%30.89%

Microbix Biosystems Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MBX
Microbix Biosystems
N/AC$0.30
-3.2%		N/A+3.4%C$41.25MC$14.81MN/AN/A
IPA
ImmunoPrecise Antibodies
N/AC$6.50
+0.8%		N/A+0.0%C$162.08MC$19.47MN/A80
HBP
Helix BioPharma
N/AC$1.42
flat		N/A+35.2%C$108.46MN/AN/A9
SCYB
Scythian Biosciences
N/AC$3.49
-5.9%		N/A+0.0%C$102.38MN/AN/AN/A
COM
138267 (COM.TO)
N/AN/AN/AN/AC$102.19MN/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:MBX) was last updated on 7/25/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel